default author photo

Osamu Sano

Takeda Pharmaceutical Company - Innovative Biology Laboratories

Japan

  • Takeda Pharmaceutical Company - Innovative Biology Laboratories

SCHOLARLY PAPERS

1

DOWNLOADS

106

TOTAL CITATIONS

0

Scholarly Papers (1)

Actions:
Email selected abstracts
1.

Identification of Hub Molecules of FUS-ALS by Bayesian Gene Regulatory Network Analysis of iPSC Model: iBRN

Number of pages: 51 Posted: 28 May 2020
Masahiro Nogami, Mitsuru Ishikawa, Atsushi Doi, Osamu Sano, Takefumi Sone, Tetsuya Akiyama, Masashi Aoki, Atsushi Nakanishi, Kazuhiro Ogi, Masato Yano and Hideyuki Okano
Takeda Pharmaceutical Company - Innovative Biology Laboratories, Keio University School of Medicine - Department of Physiology, Cell Innovator, Takeda Pharmaceutical Company - Innovative Biology Laboratories, Keio University - Department of Physiology, Tohoku University - Department of Neurology, Tohoku University Hospital - Department of Neurology, Takeda Pharmaceutical Company - Shonan Incubation Laboratories, Takeda Pharmaceutical Company - Innovative Biology Laboratories, Niigata University - Division of Neurobiology and Anatomy and Keio University School of Medicine - Department of Physiology
Downloads 106 (659,652)

Abstract:

Loading...

induced pluripotent stem cell (iPSC), Bayesian gene regulatory network analysis based on iPSC-derived cell model (iBRN), Amyotrophic lateral sclerosis (ALS), Fused in sarcoma/translated in liposarcoma (FUS), DNA damage response (DDR)